Financhill
Buy
62

CORT Quote, Financials, Valuation and Earnings

Last price:
$77.66
Seasonality move :
2.87%
Day range:
$76.40 - $78.25
52-week range:
$28.04 - $117.33
Dividend yield:
0%
P/E ratio:
66.94x
P/S ratio:
13.14x
P/B ratio:
12.05x
Volume:
1.4M
Avg. volume:
1.3M
1-year change:
145.65%
Market cap:
$8.2B
Revenue:
$675M
EPS (TTM):
$1.16

Corcept Therapeutics SEC Filings

Company Filed Form Type Description
CORT
Corcept Therapeutics
05/01/2024 10-Q 10-Q filing on 05/01/2024 View Form
CORT
Corcept Therapeutics
11/01/2023 10-Q 10-Q filing on 11/01/2023 View Form
CORT
Corcept Therapeutics
08/02/2023 10-Q 10-Q filing on 08/02/2023 View Form
CORT
Corcept Therapeutics
05/03/2023 10-Q 10-Q filing on 05/03/2023 View Form
CORT
Corcept Therapeutics
11/03/2022 10-Q 10-Q filing on 11/03/2022 View Form
CORT
Corcept Therapeutics
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
CORT
Corcept Therapeutics
05/05/2022 10-Q 10-Q filing on 05/05/2022 View Form
CORT
Corcept Therapeutics
11/03/2021 10-Q 10-Q filing on 11/03/2021 View Form
CORT
Corcept Therapeutics
07/29/2021 10-Q 10-Q filing on 07/29/2021 View Form
CORT
Corcept Therapeutics
05/06/2021 10-Q 10-Q filing on 05/06/2021 View Form
CORT
Corcept Therapeutics
11/03/2020 10-Q 10-Q filing on 11/03/2020 View Form
CORT
Corcept Therapeutics
08/04/2020 10-Q 10-Q filing on 08/04/2020 View Form
CORT
Corcept Therapeutics
05/04/2020 10-Q 10-Q filing on 05/04/2020 View Form
CORT
Corcept Therapeutics
02/24/2020 10-K 10-K filing on 02/24/2020 View Form
CORT
Corcept Therapeutics
11/07/2019 10-Q 10-Q filing on 11/07/2019 View Form
CORT
Corcept Therapeutics
08/01/2019 10-Q 10-Q filing on 08/01/2019 View Form
CORT
Corcept Therapeutics
05/09/2019 10-Q 10-Q filing on 05/09/2019 View Form
CORT
Corcept Therapeutics
02/26/2019 10-K 10-K filing on 02/26/2019 View Form
CORT
Corcept Therapeutics
11/02/2018 10-Q 10-Q filing on 11/02/2018 View Form
CORT
Corcept Therapeutics
08/09/2018 10-Q 10-Q filing on 08/09/2018 View Form
CORT
Corcept Therapeutics
05/09/2018 10-Q 10-Q filing on 05/09/2018 View Form
CORT
Corcept Therapeutics
02/28/2018 10-K 10-K filing on 02/28/2018 View Form
CORT
Corcept Therapeutics
11/03/2017 10-Q 10-Q filing on 11/03/2017 View Form
CORT
Corcept Therapeutics
08/02/2017 10-Q 10-Q filing on 08/02/2017 View Form
CORT
Corcept Therapeutics
05/02/2017 10-Q 10-Q filing on 05/02/2017 View Form
CORT
Corcept Therapeutics
03/06/2017 10-K 10-K filing on 03/06/2017 View Form
CORT
Corcept Therapeutics
11/02/2016 10-Q 10-Q filing on 11/02/2016 View Form
CORT
Corcept Therapeutics
08/03/2016 10-Q 10-Q filing on 08/03/2016 View Form
CORT
Corcept Therapeutics
05/04/2016 10-Q 10-Q filing on 05/04/2016 View Form
CORT
Corcept Therapeutics
03/10/2016 10-K 10-K filing on 03/10/2016 View Form
CORT
Corcept Therapeutics
11/06/2015 10-Q 10-Q filing on 11/06/2015 View Form
CORT
Corcept Therapeutics
08/07/2015 10-Q 10-Q filing on 08/07/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Stock Overvalued or a Buy for the Next Decade?
Is Tesla Stock Overvalued or a Buy for the Next Decade?

Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…

Is Apple Stock Undervalued or Overvalued?
Is Apple Stock Undervalued or Overvalued?

For many years, Apple (NASDAQ:AAPL) was just about the perfect…

Where Will Palo Alto Networks Stock Be in 5 Years?
Where Will Palo Alto Networks Stock Be in 5 Years?

You know those companies that just refuse to slow down…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
68
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
70
AGFY alert for May 29

Agrify [AGFY] is down 3.12% over the past day.

Buy
100
BOX alert for May 29

Box [BOX] is down 0.57% over the past day.

Sell
22
OKTA alert for May 29

Okta [OKTA] is down 0.51% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock